CLINICAL PHARMACOKINETICS OF COMMONLY USED ANTI-CANCER DRUGS

被引：95

作者：

BALIS, FM

HOLCENBERG, JS

BLEYER, WA

机构：

[1] CHILDRENS ORTHOPED HOSP & MED CTR,SEATTLE,WA 98105

[2] UNIV WASHINGTON,SEATTLE,WA 98195

[3] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104

[4] MED COLL WISCONSIN,MILWAUKEE,WI 53233

[5] MILWAUKEE CHILDRENS HOSP,MILWAUKEE,WI 53233

来源：

关键词：

D O I：

10.2165/00003088-198308030-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：202 / 232

页数：31

共 227 条

[1] ALBERTS DS, 1978, CANCER CHEMOTH PHARM, V1, P177
[2] ALBERTS DS, 1971, CLIN PHARMACOL THER, V12, P96
[3] ALBERTS DS, 1980, RECENT RES CANCER, V74, P293
[4] AN UPDATE ON THE BIOCHEMISTRY OF 5-FLUOROURACIL
ARDALAN, B
GLAZER, R
[J]. CANCER TREATMENT REVIEWS, 1981, 8 (03) : 157 - 167
[5] BACHUR NR, 1977, CLIN PHARMACOL THER, V21, P70
[6] BAGLEY CM, 1973, CANCER RES, V33, P226
[7] BALIS FM, 1983, CANCER RES
[8] BAND PR, 1973, CANCER, V32, P744, DOI 10.1002/1097-0142(197310)32:4<744::AID-CNCR2820320402>3.0.CO
[9] 2-J
[10] BATEMAN JR, 1971, CANCER-AM CANCER SOC, V28, P907, DOI 10.1002/1097-0142(1971)28:4<907::AID-CNCR2820280414>3.0.CO